Refine
Document type
- Master's Thesis (2) (remove)
Language
- English (2) (remove)
Is part of the Bibliography
- No (2)
Keywords
- India (2) (remove)
Course of studies
- MBA - International Business Management (2) (remove)
Pricing is one of the foundations of any company’s market strategy and the only factor of the marketing mix that deals with revenue generation. The other three viz. product, promotion and place deal with expenditure. Pricing strategies provide varied degrees of flexibility based on organizational capabilities and customer segments. Pricing decisions are fundamental to a firm’s growth and are complex in implementation. Based on the author’s research, value-based pricing provides the best fit for all the important pricing factors like cost structure, profit margin, competition, supply and demand, etc. Despite this, cost-based and competition-based pricing strategies are still being widely used. The IT service industry in India has long focused on the competitive advantages of cheap and abundant manpower but the lack of focus on product development together with the emergence of other low waged countries and the growing nature of technology adaptation in the country have presented significant motivation to these IT firms to invest in research and development aimed at enhancing their product portfolio, which can be best taken advantage of by moving their pricing decisions towards a customer-value centric approach. Basing their prices on the different customer segments and focusing on value generation is the best way forward in the face of increased competition from both domestic and international organizations.
Patient engagement is the most important element in the process of research/development of medicinal products and healthcare management in today’s times. In a country like India which has a huge population and limited state of regulatory affairs it becomes important to walk the extra mile to protect the patient lives and truly serve them. Time and again it is seen that there is no or limited focus on patient centric processes and we still tend to focus on sponsors as the key stakeholder.
The author in this thesis aims to focus on the clinical trial landscape of India and determine if there is a need to improve the clinical trial processes. If yes, then what type of change is the audience looking for.
The author tries to introduce the human element in the process and remind us all that it is the ‘patients’ who are the centre for the drug development process and serving them and alleviating their pain in the true purpose of the process.
The author along with the helping us find a definition of patient centricity in India, also proposes a model that can be used by the Indian pharmaceutical companies to focus on patient centricity at different stages of the drug development cycle within their organisations.d